HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L'Oreal's Consumer Brands Drive North America Sales, Share Gains

This article was originally published in The Rose Sheet

Executive Summary

Maybelline, L’Oreal Paris and Garnier led a 7.9% sales increase on a like-for-like basis in North America in the second fiscal quarter, L’Oreal reports July 26. CEO Jean-Paul Agon tells analysts the firm was the “leader in innovation” in cosmetics in all continents and retail channels.

You may also be interested in...



Maybelline SuperStay Items Not True To Name – Consumer Suit

Lawsuit seeking class-action status against Maybelline LLC alleges that long-staying claims for the firm’s SuperStay 10HR Stain Gloss and 14HR Lipstick are “misleading, inaccurate and deceptive.” Filed in federal court in New York, suit seeks damages and permanent injunction enjoining future such claims.

L'Oreal Banking On “Major” Product Launches In 2012 Second Half

L’Oreal will launch three major new fragrances that will help boost its cosmetics sales beyond the projected growth rate of the overall global cosmetics market this year, firm states in Aug. 29 earnings report. Net operating profit advanced 11.4% to $2.37 billion in first half.

L'Oreal “New Markets” Sales Surpass Western Europe In Q1

L’Oreal’s sales in Eastern Europe, Asia Pacific, Latin America and Africa/Middle East made up 39.4% of its total cosmetics sales for the first quarter, surpassing Western Europe at 36.8%. The firm’s luxury unit continues to enjoy strong momentum, booking €1.32 billion ($1.73 billion) in sales, up 12.2% from the prior-year period.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018220

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel